Long-term efficacy and limitations of cyclophosphamide in myasthenia gravis.

Nagappa, M

Long-term efficacy and limitations of cyclophosphamide in myasthenia gravis. [electronic resource] - Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia Nov 2014 - 1909-14 p. digital

Publication Type: Journal Article

1532-2653

10.1016/j.jocn.2014.03.019 doi


Adult
Combined Modality Therapy
Cyclophosphamide--administration & dosage
Drug Evaluation
Drug Substitution
Drug Therapy, Combination
Female
Follow-Up Studies
Gastrointestinal Diseases--chemically induced
Hematologic Diseases--chemically induced
Humans
Immunosuppressive Agents--administration & dosage
Infections--etiology
Kidney Diseases--chemically induced
Male
Middle Aged
Myasthenia Gravis--drug therapy
Plasma Exchange
Pulse Therapy, Drug
Pyridostigmine Bromide--therapeutic use
Remission Induction
Respiration, Artificial
Retrospective Studies
Thymectomy
Treatment Outcome
Young Adult